Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trialBruno François, Thorbjørn Grøfte, Simon Lambden et al.|The Lancet Respiratory Medicine|2023Cited by 76
Admission of tetanus patients to the ICU: a retrospective multicentre studyRafaël Mahieu, Nicolas Lerolle, Steven Grangé et al.|Annals of Intensive Care|2017Cited by 45
Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trialBruno François, Sébastien Gibot, Simon Lambden et al.|EClinicalMedicine|2023Cited by 18
Extracranial anticoagulant related bleedings admitted to intensive care units: a French multicenter retrospective studyThomas Botrel, Hafid Ait‐Oufella, Sibylle Cunat et al.|Critical Care|2023Cited by 4